Published on
November 22, 2022
- 21:40 GMT
uniQure announces FDA approval of first gene therapy for adults with hemophilia B
~ Historic approval provides a new treatment option that reduces the rate of annual bleeds, reduces or eliminates the need for prophylactic therapy, and generates elevated and sustained factor IX levels ~ ~ uniQure conducted the multi-year clinical …
Distribution channels:
Companies, Media, Advertising & PR
...
